GMOFORUM.AGROBIOLOGY.EU :  Phorum 5 The fastest message board... ever.
GMO RAUPP.INFO forum provided by WWW.AGROBIOLOGY.EU 
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
European Commission supports new developments in biotechnology
Posted by: Prof. Dr. M. Raupp (IP Logged)
Date: December 21, 2005 08:37AM

www.checkbiotech.org ; www.raupp.info ; www.czu.cz

The European Commission today presents ?100 Technology offers stemming from
EU Biotechnology RTD results?, a catalogue of biotechnology developments
arising from EU-funded research projects over the last 10 years, December
2005.

This guide will help to put researchers and companies in contact,
hopefully leading to new and innovative products and processes based on this
research. Examples featured in the catalogue include applications for food
and plant biotechnology, biopharmaceuticals and biomedical technologies to
support diagnostics and therapy. Each technology offer is described,
including its potential for future commercial exploitation, and contact
details are given for the researchers and the owners. ?100 Technology
Offers? is an example of how the European Commission is supporting the
transformation of research into innovation.

?Growth and jobs are fuelled by innovation and innovation is fed by
research?, said Janez Poto?nik, European Commissioner for Science and
Research. ?With this publication, the Commission is helping researchers to
make their results known and put new technologies at the disposal of
industry that can make the most of them.?

?100 biotechnology offers? includes results from the 4th, 5th and 6th
Framework Programmes. Examples include:


A small Slovenian company, BIA separations, which recently defended its
intellectual property at the European Patent Office against big industry.
The issue is one of monolithic chromatographic supports, which are used for
the purification of pharmaceuticals and biologicals;


Belgian start-up Cilbiotech, which improves the scale-up of cell cultivation
for the production of human and veterinary vaccines. This new technology can
for example increase the coverage of vaccines that may not currently be
available to some sections of the population due to allergies.


All examples show that technologies developed by small biotech companies are
ripe for future exploitation, and that issues relating to intellectual
property need to be resolved if this is to take place in the best way.

Over the last 5-10 years, the Commission has required projects to develop a
technological implementation plan, as part of making scientists aware of
issues relating to intellectual property and entrepreneurship.

An online version of the booklet can be downloaded from:
[www.cordis.europa.eu.int]

------------------------------------------
Posted to Phorum via PhorumMail



Sorry, only registered users may post in this forum.
This forum powered by Phorum.